Healthcare Resource Utilization (HCRU) and Associated Costs Among Patients With Acute Myeloid Leukemia (AML) Treated With Oral Azacitidine as Maintenance and Those Eligible But Not Treated Using a US Claims Database
Author Type(s)
Faculty
Document Type
Abstract
Publication Date
12-2023
Journal Title
Value in Health
Department
Medicine
Recommended Citation
Borate, U., Seiter, K., Potluri, R., Mazumder, D., Heydendael, W., Chevli, M., Prebet, T., Strocchia, M., Vasconcelos, A., & Sieluk, J. (2023). Healthcare Resource Utilization (HCRU) and Associated Costs Among Patients With Acute Myeloid Leukemia (AML) Treated With Oral Azacitidine as Maintenance and Those Eligible But Not Treated Using a US Claims Database. Value in Health, 26 (11), S2. Retrieved from https://touroscholar.touro.edu/nymc_fac_abstracts/935
COinS
